Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited On 27 October 2022, the Board received the resignation letter of Mr. Zhang Ping ("Mr. Zhang"), pursuant to which Mr. Zhang gave notice of his resignation as Director of the Company due to job assignment changes (the "Resignation"). Following the Resignation, Mr. Zhang no longer holds any position in the Company.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Singapore S.E.
Equities
T14
CNE100000924
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2 USD | +1.52% | +0.50% | -3.38% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+37.37% | 6.02B | |
-15.69% | 4.49B | |
-12.46% | 3.06B | |
+0.47% | 2.61B | |
+36.06% | 1.81B | |
+0.84% | 1.66B | |
-10.60% | 1.63B | |
-12.03% | 1.55B | |
+36.40% | 1.41B |
- Stock Market
- Equities
- 600329 Stock
- T14 Stock
- News Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
- Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Resignation of Zhang as Director